News | Weill Department of Medicine

Study Finds Heart Failure Training and Technology Support for Home Health Aides Improves Patient Care

Combining heart failure education with real-time communication tools can better equip home health aides (HHAs) to care for adults with heart failure in the home, according to a pilot randomized clinical trial conducted by researchers in the Division of General Internal Medicine at Weill Cornell Medicine and VNS Health, one of the largest home care agencies in the United States, located in New York City. The study, published in JAMA Network Open, was funded by National Heart, Lung, and Blood... Read More

Weill Department of Medicine to Host 10th Annual Research Retreat Day

This Friday, Nov. 14th, from 9 am to 1:30 p.m., the Weill Department of Medicine will host its 10th annual Research Retreat Day.Organized by Dr. Myles Wolf, Chair, Dr. Kyu Rhee, Professor and Vice Chair of Research, and Dr. Gregory Sonnenberg, Professor and Associate Vice Chair of Research, this highly collaborative event will bring together a diverse range of established and emerging faculty, trainees, and experts in complementary fields to foster and expand the Department's research efforts.... Read More

Galvanizing Blood Vessel Cells to Expand for Organ Transplantation

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for transplantation, according to a preclinical study by Weill Cornell Medicine investigators. Endothelial cells form the inner lining of blood vessels and regulate blood flow, inflammation and healing. Traditional approaches for growing these cells in the lab have yielded only limited... Read More

Gut Neurons Help the Body Fight Inflammation

Neurons in the gut produce a molecule that plays a pivotal role in shaping the gut’s immune response during and after inflammation, according to a new study by Weill Cornell Medicine investigators. The findings suggest that targeting these neurons and the molecules they produce could open the door to new treatments for inflammatory bowel disease and other disorders driven by gut inflammation.Hundreds of millions of neurons make up the enteric nervous system, the “second brain” of the body,... Read More

NIH Grant Funds Effort to Target the Root of HIV Persistence

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find ways to remove latent HIV from the cells of individuals with HIV. The team aims to use a personalized medicine approach to transform the management of HIV into effective cures.Over 40 million people worldwide are living with HIV, according to the World Health Organization. People... Read More

Hurricane Sandy Linked to Lasting Heart Disease Risk in Elderly

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.The study, published Sept. 3 in JAMA Network Open, found that older adults living in flood-hit areas in New Jersey faced a 5% higher risk of heart disease for up to five years after Sandy’s landfall. This is one of the first studies to rigorously quantify long-term... Read More

Addressing Arthritis and Functional Limitations Among Home Health Care Workers

Home health care aides face significantly higher rates of arthritis and functional disability compared to health care aides working in hospitals or long-term care facilities, according to researchers at Weill Cornell Medicine and the National Institute for Occupational Safety and Health (NIOSH). The recent study, published in the Journal of the American Geriatrics Society, raises critical concerns about how the demands of home care work are affecting the health of caregivers, especially... Read More

Pig Liver Trial May Offer Hope for Patients with Severe Liver Failure

The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in the U.S. to use a genetically engineered pig liver to support patients with severe liver failure who don’t qualify for a transplant, according to an American Journal of Transplantation (AJT) report published in August.“We’ve waited over two decades since the last trial of a bioartificial liver device,” says Dr. Robert Brown, Chief of the Division of Gastroenterology and Hepatology and a leading physician in... Read More

New Study Supports Combined Colon and Endometrial Screening Approach for Lynch Syndrome Patients

A new study co-authored by Dr. Felice Schnoll-Sussman, Director of the Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian and Weill Cornell Medicine, shows promising results for combined colon and endometrial screening for patients with Lynch syndrome, a genetic condition in which individuals face up to a 60% lifetime risk of developing endometrial and gastrointestinal cancers.This patient-centric program evolved from the desire to improve the quality of life and quality of... Read More

Congratulations to our 2025 Fund for the Future Awardees

The Fund for the Future award supports selected junior faculty during a crucial period in their career development - the completion of their research training into the early years of their first faculty position at Weill Cornell Medicine. Backed by the generosity of donors to the Weill Department of Medicine (WDOM) and Iris Cantor Center for Women’s Health, funding is based upon academic progress and a competitive training award (such as an NIH K) application timeline within 18 months of... Read More